Parallel Advisors, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$75,520
+2.4%
623
-3.3%
0.00%
+50.0%
Q2 2023$73,751
+222.3%
644
+288.0%
0.00%
+100.0%
Q1 2023$22,880
+9.7%
166
+3.1%
0.00%0.0%
Q4 2022$20,862
-57.4%
161
-63.5%
0.00%
-50.0%
Q3 2022$49,000
+81.5%
441
+23.5%
0.00%
+100.0%
Q2 2022$27,000
-6.9%
357
-4.8%
0.00%0.0%
Q1 2022$29,000
-32.6%
375
-22.0%
0.00%
-50.0%
Q4 2021$43,000
+22.9%
481
+26.2%
0.00%
+100.0%
Q3 2021$35,000
+105.9%
381
+74.0%
0.00%0.0%
Q2 2021$17,000
+30.8%
219
+21.7%
0.00%0.0%
Q1 2021$13,000
+8.3%
180
+150.0%
0.00%0.0%
Q4 2020$12,000
+9.1%
72
-10.0%
0.00%0.0%
Q3 2020$11,000
-8.3%
800.0%0.00%0.0%
Q2 2020$12,000
+50.0%
80
-2.4%
0.00%0.0%
Q1 2020$8,000
+14.3%
82
+57.7%
0.00%0.0%
Q4 2019$7,000
+133.3%
52
+36.8%
0.00%
Q3 2019$3,000
-75.0%
38
-53.1%
0.00%
-100.0%
Q2 2019$12,000
+9.1%
81
-9.0%
0.00%0.0%
Q1 2019$11,000
+120.0%
89
+74.5%
0.00%0.0%
Q4 2018$5,000
-16.7%
51
+30.8%
0.00%0.0%
Q3 2018$6,000
+100.0%
39
+34.5%
0.00%
Q2 2018$3,000
+50.0%
290.0%0.00%
Q1 2018$2,0000.0%290.0%0.00%
Q4 2017$2,0000.0%290.0%0.00%
Q3 2017$2,000
-84.6%
29
-91.2%
0.00%
-100.0%
Q2 2017$13,000
+550.0%
329
+467.2%
0.00%
Q1 2017$2,000580.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders